Search results for: “biopharmaceutical”
-
Faron Pharmaceuticals appoints Dr. Juho Jalkanen as new CEO, as Dr. Markku steps down
•
TURKU, FINLAND: Faron Pharmaceuticals Ltd. (AIM: FARN), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid…
-
PanTher Therapeutics appoints John Edwards as Executive Chair
•
PanTher Therapeutics, a pioneer in localized cancer treatment, has announced the appointment of John Edwards as the Executive…
-
Alterome Therapeutics raises $132 million in Series B led by Goldman Sachs Alternatives
•
SAN DIEGO: Alterome Therapeutics, Inc., a trailblazer in the biopharmaceutical industry, has successfully completed a Series B financing…
-
AstraZeneca to acquire Fusion Pharmaceuticals in a $ 2.0 billion deal
•
LONDON: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing…
-
How to fund your women-owned business in 2024
•
Funding is one of the most important and challenging aspects of running a business, especially for women entrepreneurs.…
-
Saama and Pfizer expand AI partnership to accelerate clinical trials
•
Saama, a leading provider of AI-based solutions for clinical development and commercialization, announced a new multi-year agreement with…
-
AstraZeneca reports strong growth in 2023 despite COVID-19 challenges
•
AstraZeneca, a global biopharmaceutical company, announced its financial results for the full year 2023, showing a 6% increase…
-
Abivax appoints Ana Sharma as Vice President, Global Head of Quality
•
PARIS, FRANCE: Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory…
-
CG Oncology goes public with $380 million IPO, Malin’s stake rises in value
•
LONDON, UK: CG Oncology, a biotechnology company focused on cancer immunotherapy, has launched its initial public offering (IPO)…
-
RTW BIO completes investment in Arix Bioscience ahead of merger
•
LONDON, UK: RTW BIO, a biopharmaceutical and medical technology investment company, has completed its investment in Arix Bioscience,…
-
Cyclo Therapeutics and Applied Molecular Transport complete merger deal
•
Cyclo Therapeutics, Inc. (Nasdaq: CYTH), a clinical stage biotechnology company, and Applied Molecular Transport Inc. (Nasdaq: AMTI), a…
-
Bristol Myers Squibb to buy RayzeBio for $4.1 billion in cash
•
Bristol Myers Squibb (BMY), a leading biopharmaceutical company, announced today that it has agreed to acquire RayzeBio (RYZB),…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.